Exploratory study on the effect of osteoactivin on bone formation in the rat critical-size calvarial defect model

J. P. Bateman, F. F. Safadi, C. Susin, U. M E Wikesjö

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background and Objective: Osteoactivin is a novel glycoprotein shown to exhibit an important role in regulating osteoblast differentiation and function. The aim of the present study was to evaluate the potential of osteoactivin to support bone regeneration using an established defect model. Material and Methods: Critical-size, 8-mm-diameter through-and-through calvarial osteotomy defects were created in 60 adult male Sprague-Dawley rats. Test animals received 0.1mL of osteoactivin in phosphate-buffered saline (50μg/mL) soak-loaded onto an absorbable collagen sponge. Controls received 0.1mL of phosphate-buffered saline soak-loaded onto the absorbable collagen sponge or no further intervention (sham-surgery). The animals were euthanized 2 and 4wk after treatment and histometric analyses were performed. Results: The absorbable collagen sponge control (mean±standard deviation: 40.9±26.9%) showed borderline significant greater bone fill compared with sham-surgery (22.9±15.8%; p=0.10) and osteoactivin (20.2±11.8%; p=0.07) treatments at 2wk. In contrast, osteoactivin (84.7±15.8%) showed significantly greater bone fill than sham-surgery (28.4±9.6%; p<0.001) and absorbable collagen sponge (41.8±22.1%; p<0.001) at 4wk. No animals receiving sham-surgery or absorbable collagen sponge exhibited complete bone fill at 4wk while 70% of the animals receiving osteoactivin showed complete bone fill. Conclusion: Osteoactivin demonstrates a significant potential to support bone regeneration/formation. Studies using discriminating large animal models are necessary to explore clinical application for periodontal and craniofacial indications.

Original languageEnglish (US)
Pages (from-to)243-247
Number of pages5
JournalJournal of Periodontal Research
Volume47
Issue number2
DOIs
StatePublished - Apr 1 2012

Fingerprint

Porifera
Osteogenesis
Collagen
Bone and Bones
Bone Regeneration
Phosphates
Osteotomy
Osteoblasts
Sprague Dawley Rats
Glycoproteins
Animal Models
Therapeutics

Keywords

  • Bone
  • Craniofacial
  • Gpnmb protein
  • Osteoactivin
  • Rat model
  • Tissue engineering

ASJC Scopus subject areas

  • Periodontics

Cite this

Exploratory study on the effect of osteoactivin on bone formation in the rat critical-size calvarial defect model. / Bateman, J. P.; Safadi, F. F.; Susin, C.; Wikesjö, U. M E.

In: Journal of Periodontal Research, Vol. 47, No. 2, 01.04.2012, p. 243-247.

Research output: Contribution to journalArticle

Bateman, J. P. ; Safadi, F. F. ; Susin, C. ; Wikesjö, U. M E. / Exploratory study on the effect of osteoactivin on bone formation in the rat critical-size calvarial defect model. In: Journal of Periodontal Research. 2012 ; Vol. 47, No. 2. pp. 243-247.
@article{803c79dfdd4a45a2b7654ddada88c2f1,
title = "Exploratory study on the effect of osteoactivin on bone formation in the rat critical-size calvarial defect model",
abstract = "Background and Objective: Osteoactivin is a novel glycoprotein shown to exhibit an important role in regulating osteoblast differentiation and function. The aim of the present study was to evaluate the potential of osteoactivin to support bone regeneration using an established defect model. Material and Methods: Critical-size, 8-mm-diameter through-and-through calvarial osteotomy defects were created in 60 adult male Sprague-Dawley rats. Test animals received 0.1mL of osteoactivin in phosphate-buffered saline (50μg/mL) soak-loaded onto an absorbable collagen sponge. Controls received 0.1mL of phosphate-buffered saline soak-loaded onto the absorbable collagen sponge or no further intervention (sham-surgery). The animals were euthanized 2 and 4wk after treatment and histometric analyses were performed. Results: The absorbable collagen sponge control (mean±standard deviation: 40.9±26.9{\%}) showed borderline significant greater bone fill compared with sham-surgery (22.9±15.8{\%}; p=0.10) and osteoactivin (20.2±11.8{\%}; p=0.07) treatments at 2wk. In contrast, osteoactivin (84.7±15.8{\%}) showed significantly greater bone fill than sham-surgery (28.4±9.6{\%}; p<0.001) and absorbable collagen sponge (41.8±22.1{\%}; p<0.001) at 4wk. No animals receiving sham-surgery or absorbable collagen sponge exhibited complete bone fill at 4wk while 70{\%} of the animals receiving osteoactivin showed complete bone fill. Conclusion: Osteoactivin demonstrates a significant potential to support bone regeneration/formation. Studies using discriminating large animal models are necessary to explore clinical application for periodontal and craniofacial indications.",
keywords = "Bone, Craniofacial, Gpnmb protein, Osteoactivin, Rat model, Tissue engineering",
author = "Bateman, {J. P.} and Safadi, {F. F.} and C. Susin and Wikesj{\"o}, {U. M E}",
year = "2012",
month = "4",
day = "1",
doi = "10.1111/j.1600-0765.2011.01428.x",
language = "English (US)",
volume = "47",
pages = "243--247",
journal = "Journal of Periodontal Research",
issn = "0022-3484",
publisher = "Blackwell Munksgaard",
number = "2",

}

TY - JOUR

T1 - Exploratory study on the effect of osteoactivin on bone formation in the rat critical-size calvarial defect model

AU - Bateman, J. P.

AU - Safadi, F. F.

AU - Susin, C.

AU - Wikesjö, U. M E

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Background and Objective: Osteoactivin is a novel glycoprotein shown to exhibit an important role in regulating osteoblast differentiation and function. The aim of the present study was to evaluate the potential of osteoactivin to support bone regeneration using an established defect model. Material and Methods: Critical-size, 8-mm-diameter through-and-through calvarial osteotomy defects were created in 60 adult male Sprague-Dawley rats. Test animals received 0.1mL of osteoactivin in phosphate-buffered saline (50μg/mL) soak-loaded onto an absorbable collagen sponge. Controls received 0.1mL of phosphate-buffered saline soak-loaded onto the absorbable collagen sponge or no further intervention (sham-surgery). The animals were euthanized 2 and 4wk after treatment and histometric analyses were performed. Results: The absorbable collagen sponge control (mean±standard deviation: 40.9±26.9%) showed borderline significant greater bone fill compared with sham-surgery (22.9±15.8%; p=0.10) and osteoactivin (20.2±11.8%; p=0.07) treatments at 2wk. In contrast, osteoactivin (84.7±15.8%) showed significantly greater bone fill than sham-surgery (28.4±9.6%; p<0.001) and absorbable collagen sponge (41.8±22.1%; p<0.001) at 4wk. No animals receiving sham-surgery or absorbable collagen sponge exhibited complete bone fill at 4wk while 70% of the animals receiving osteoactivin showed complete bone fill. Conclusion: Osteoactivin demonstrates a significant potential to support bone regeneration/formation. Studies using discriminating large animal models are necessary to explore clinical application for periodontal and craniofacial indications.

AB - Background and Objective: Osteoactivin is a novel glycoprotein shown to exhibit an important role in regulating osteoblast differentiation and function. The aim of the present study was to evaluate the potential of osteoactivin to support bone regeneration using an established defect model. Material and Methods: Critical-size, 8-mm-diameter through-and-through calvarial osteotomy defects were created in 60 adult male Sprague-Dawley rats. Test animals received 0.1mL of osteoactivin in phosphate-buffered saline (50μg/mL) soak-loaded onto an absorbable collagen sponge. Controls received 0.1mL of phosphate-buffered saline soak-loaded onto the absorbable collagen sponge or no further intervention (sham-surgery). The animals were euthanized 2 and 4wk after treatment and histometric analyses were performed. Results: The absorbable collagen sponge control (mean±standard deviation: 40.9±26.9%) showed borderline significant greater bone fill compared with sham-surgery (22.9±15.8%; p=0.10) and osteoactivin (20.2±11.8%; p=0.07) treatments at 2wk. In contrast, osteoactivin (84.7±15.8%) showed significantly greater bone fill than sham-surgery (28.4±9.6%; p<0.001) and absorbable collagen sponge (41.8±22.1%; p<0.001) at 4wk. No animals receiving sham-surgery or absorbable collagen sponge exhibited complete bone fill at 4wk while 70% of the animals receiving osteoactivin showed complete bone fill. Conclusion: Osteoactivin demonstrates a significant potential to support bone regeneration/formation. Studies using discriminating large animal models are necessary to explore clinical application for periodontal and craniofacial indications.

KW - Bone

KW - Craniofacial

KW - Gpnmb protein

KW - Osteoactivin

KW - Rat model

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84857449122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857449122&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0765.2011.01428.x

DO - 10.1111/j.1600-0765.2011.01428.x

M3 - Article

VL - 47

SP - 243

EP - 247

JO - Journal of Periodontal Research

JF - Journal of Periodontal Research

SN - 0022-3484

IS - 2

ER -